Cartesian Therapeutics Inc (RNAC)
SG&A Expense Growth
22.63%
Quarterly · Period ending:
RNAC SG&A Expense Growth
Latest reported22.63%period ending
Latest reported22.63%period ending
RNAC Quarterly SG&A Growth (QoQ) (0.00% → 22.63%)
Latest values, visible window
High-resolution chart · PNG
RNAC sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 22.6314% | |
| -13.2122% | |
| 6.2338% | |
| 6.5746% | |
| -12.9284% | |
| 17.3275% | |
| 8.0006% | |
| -6.6173% | |
| -25.6402% | |
| -57.3691% | |
| 235.1527% | |
| 8.3374% | |
| 7.1993% | |
| -0.3848% | |
| 9.2908% | |
| -8.7563% | |
| 17.1674% | |
| -11.6946% | |
| 1.7631% | |
| 14.6799% | |
| -8.7625% | |
| 9.3737% | |
| 7.6471% | |
| -21.5895% | |
| 37.5549% | |
| 0.6385% | |
| 10.3523% | |
| -10.3063% | |
| -8.8411% | |
| -12.3008% | |
| 26.8738% | |
| -7.0151% | |
| -6.6752% | |
| -17.5807% | |
| 29.5636% | |
| -10.7281% | |
| 26.529% | |
| -32.6906% | |
| 130.7415% | |
| 3.1844% | |
| 1.554% | |
| 17.2906% | |
| -7.5171% | |
| -1.9214% | |
| 19.5513% | |
| 0% |